AI Tech Suite

Silica Corpora

Click to visit website

About

Silica Corpora is a therapeutics company focused on developing next-generation antibody therapeutics using Generative AI. Their proprietary AI platform utilizes Foundation Models for de novo antibody design, allowing for the discovery of relevant antibody candidates from amino acid sequences. The platform enhances the accuracy and efficiency of the drug discovery process, reducing the number of antibodies requiring experimental testing in pre-clinical trials. Silica Corpora is committed to establishing strategic partnerships, utilizing existing data to create tailored models that improve future drug candidates without disrupting in vitro workflows, thereby making integration seamless. Their holistic approach leverages progress in Generative AI to enable quality antibody generation without the need for traditional in vitro or in vivo methods.